CLINICAL RESEARCH: TREATMENT STANDARDS FOR ACUTE INFARCTION
Duration of Ischemia Is a Major Determinant of Transmurality and Severe Microvascular Obstruction After Primary Angioplasty
A Study Performed With Contrast-Enhanced Magnetic Resonance
Giuseppe Tarantini, MD, PhD*,
Luisa Cacciavillani, MD*,
Francesco Corbetti, MD ,*,
Angelo Ramondo, MD*,
Martina Perazzolo Marra, MD*,
Enrico Bacchiega, MD*,
Massimo Napodano, MD*,
Claudio Bilato, MD, PhD*,
Renato Razzolini, MD* and
Sabino Iliceto, MD, FACC*
* Department of Cardiac, Thoracic, and Vascular Sciences
Department of Radiology, University of Padova Medical School, Padua, Italy. A grant was received from Boehringer Ingelheim
Manuscript received September 23, 2004;
revised manuscript received May 25, 2005,
accepted June 7, 2005.
* Reprint requests and correspondence: Dr. Giuseppe Tarantini, Department of Cardiac, Thoracic, and Vascular Sciences, Policlinico Universitario, Via Giustiniani, 2, 35128 Padova, Italy
(Email: giuseppe.tarantini.1{at}unipd.it).
OBJECTIVES: This study sought to assess the relationship between duration of ischemia and both myocardial transmural necrosis (TN) and severe microvascular obstruction (SMO), by contrast-enhanced magnetic resonance (CE-MR), in patients with acute myocardial infarction (AMI) treated with angioplasty (PCI), and to estimate the risk of TN and SMO with the duration of ischemia.
BACKGROUND: The impact of ischemic time on myocardial and microvascular injury is not well characterized in people.
METHODS: We performed CE-MR in 77 patients with first AMI, 5 ± 3 days after successful PCI. The AMI was labeled as transmural if hyperenhancement at CE-MR was extended to 75% of the thickness in two or more ventricular segments. The SMO was identified as areas of late hypoenhancement surrounded by hyperenhanced tissue. The relationship between ischemic time and CE-MR evidence of SMO or TN was evaluated by logistic regression.
RESULTS: Thirteen patients were excluded because of preprocedural Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 of the infarct-related artery. For the remaining 64 patients, the mean time to treatment was 190 ± 110 min, 45 (65%) patients had TN and 23 (39%) had SMO. Mean pain to balloon time was 90 ± 40 min, 110 ± 107 min, and 137 ± 97 min in patients without TN and SMO, with TN but without SMO, or with both TN and SMO, respectively (p = 0.001). Multivariate analysis showed that time delay was significantly associated both with TN (odds ratio per 30 min, 1.37, p = 0.032), and SMO (odds ratio per 30 min, 1.21; p = 0.021).
CONCLUSIONS: In AMI patients with impaired coronary perfusion undergoing PCI, the risk of TN and SMO increases with the duration of the ischemic time.
|
Abbreviations and Acronyms
| | AMI = acute myocardial infarction | | CE-MR = contrast-enhanced magnetic resonance | | MBG = myocardial blush grade | | PCI = percutaneous coronary intervention | | SMO = severe microvascular obstruction | | TIMI = Thrombolysis In Myocardial Infarction | | TN = transmural necrosis |
|
This article has been cited by other articles:

|
 |

|
 |
 
Y. Mikami, H. Sakuma, M. Nagata, M. Ishida, T. Kurita, I. Komuro, and M. Ito
Relation Between Signal Intensity on T2-Weighted MR Images and Presence of Microvascular Obstruction in Patients With Acute Myocardial Infarction
Am. J. Roentgenol.,
October 1, 2009;
193(4):
W321 - W326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. O'Regan, R. Ahmed, C. Neuwirth, Y. Tan, G. Durighel, J. V. Hajnal, I. Nadra, S. J. Corbett, and S. A. Cook
Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention
Am J Physiol Heart Circ Physiol,
July 1, 2009;
297(1):
H340 - H346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Napodano, A. Ramondo, G. Tarantini, D. Peluso, S. Compagno, C. Fraccaro, A. C. Frigo, R. Razzolini, and S. Iliceto
Predictors and time-related impact of distal embolization during primary angioplasty
Eur. Heart J.,
February 1, 2009;
30(3):
305 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G De Luca, C M Gibson, F Bellandi, S Murphy, M Maioli, M Noc, U Zeymer, D Dudek, H-R Arntz, S Zorman, et al.
Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis
Heart,
December 1, 2008;
94(12):
1548 - 1558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. De Luca
Adjunctive antithrombotic therapy during primary percutaneous coronary intervention
Eur. Heart J. Suppl.,
December 1, 2008;
10(suppl_J):
J2 - J14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F Younger, S. Plein, J. Barth, J. P Ridgway, S. G Ball, and J. P Greenwood
Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction
Heart,
December 1, 2007;
93(12):
1547 - 1551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Granger and M. R. Patel
The Search for Myocardial Protection: Is There Still Hope?
J. Am. Coll. Cardiol.,
July 31, 2007;
50(5):
406 - 408.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Thiele, M. J. Kappl, A. Linke, S. Erbs, E. Boudriot, A. Lembcke, D. Kivelitz, and G. Schuler
Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging
Eur. Heart J.,
June 6, 2007;
(2007)
ehm173v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Eur. Heart J.,
April 1, 2007;
28(7):
788 - 797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Keeley and L. D. Hillis
Primary PCI for Myocardial Infarction with ST-Segment Elevation
N. Engl. J. Med.,
January 4, 2007;
356(1):
47 - 54.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, C. Serantoni, M. Aquilina, S. Silenzi, F. Baldazzi, D. Grosseto, et al.
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction
Eur. Heart J.,
July 1, 2006;
27(13):
1550 - 1557.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|